Hepatitis C virus nonstructural protein 3, nonstructural protein 4A, nonstructural protein 4B, nonstructural protein 5A, nonstructural protein 5B (NS3, NS4A, NS4B, NS5A, NS5B)

The Hepatitis C virus encodes several nonstructural proteins critical for its life cycle, specifically NS3, NS4A, NS4B, NS5A, and NS5B. NS3 is a large multifunctional enzyme with serine protease and RNA helicase activity, and NS4A acts as its essential cofactor, together responsible for polyprotein processing. NS4B is a membrane-associated protein that induces structural changes for viral replication complexes. NS5A is a phosphoprotein involved in viral replication, modulation of cellular signaling, and resistance to interferons, while NS5B is an RNA-dependent RNA polymerase conducting viral genome replication. These nonstructural proteins are the principal therapeutic targets for direct-acting antivirals, revolutionizing HCV treatment by enabling high cure rates and oral therapy regimes. Resistance mutations in these target proteins can reduce drug efficacy and are monitored for personalized treatment decisions.

Other names

HCV NS3HCV NS4AHCV NS4BHCV NS5AHCV NS5BNon-structural proteins of HCV

Protease inhibitors block NS3 protease, preventing polyprotein processing and viral maturation. Polymerase inhibitors block NS5B RNA polymerase, halting viral RNA replication. NS5A inhibitors disrupt viral RNA replication and assembly, and inhibit immune evasion functions.